title: "What should happen before asymptomatic men decide whether or not to have a PSA test?" A report on three community juries.
abstract: OBJECTIVE
  To elicit the views of well informed community members on the ethical obligations of general practitioners regarding prostate-specific antigen (PSA) testing, and what should be required before a man undergoes a PSA test.
  
  
  METHODS
  Three community juries held at the University of Sydney over 6 months in 2014.
  
  
  METHODS
  Forty participants from New South Wales, of diverse social and cultural backgrounds and with no experience of prostate cancer, recruited through public advertising: two juries of mixed gender and ages; one all-male jury of PSA screening age.
  
  
  RESULTS
  In contrast to Royal Australian College of General Practitioners guidelines, the three juries concluded that GPs should initiate discussions about PSA testing with asymptomatic men over 50 years of age. The mixed juries voted for GPs offering detailed information about all potential consequent benefits and harms before PSA testing, and favoured a cooling-off period before undertaking the test. The all-male jury recommended a staggered approach to providing information. They recommended that written information be available to those who wanted it, but eight of the 12 jurors thought that doctors should discuss the benefits and harms of biopsy and treatment only after a man had received an elevated PSA test result.
  
  
  CONCLUSIONS
  Informed jury participants preferred that GPs actively supported individual men in making decisions about PSA testing, and that they allowed a cooling-off period before testing. However, men of screening age argued that uncertain and detailed information should be communicated only after receiving an elevated PSA test result.
authors.affiliation: University of Sydney, Sydney, NSW chris.degeling@sydney.edu.au.
authors.forename: Chris
authors.initials: C
authors.lastname: Degeling
authors.affiliation: University of Notre Dame, Sydney, NSW.
authors.forename: Lucie
authors.initials: L
authors.lastname: Rychetnik
authors.affiliation: University of Sydney, Sydney, NSW.
authors.forename: Kristen
authors.initials: K
authors.lastname: Pickles
authors.affiliation: Bond University, Gold Coast, QLD.
authors.forename: Rae
authors.initials: R
authors.lastname: Thomas
authors.affiliation: Bond University, Gold Coast, QLD.
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Doust
authors.affiliation: The University of Queensland Centre for Clinical Research, Redland City, QLD.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Gardiner
authors.affiliation: Bond University, Gold Coast, QLD.
authors.forename: Paul
authors.initials: P
authors.lastname: Glasziou
authors.affiliation: University of Sydney, Sydney, NSW.
authors.forename: Ainsley J
authors.initials: AJ
authors.lastname: Newson
authors.affiliation: University of Sydney, Sydney, NSW.
authors.forename: Stacy M
authors.initials: SM
authors.lastname: Carter
mesh_terms: D000368:Aged; D001291:Attitude of Health Personnel; D005260:Female; D058006:General Practice; D006801:Humans; D008297:Male; D008875:Middle Aged; D009517:New South Wales; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis
chemical_list: D017430:Prostate-Specific Antigen